Laser Delivery System for Eye Surgery
A patent family: one line of work, grouped by real continuity rather than by a technology label
inferred from titles. 5 of these applications claim priority to application 61/619,386, filed Apr 2, 2012. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
| Patent | Title | Holder | Status | Expires | Time remaining | Confidence |
|---|---|---|---|---|---|---|
| US 11,147,708 | Combined Laser and Phacoemulsification System for Eye Surgery In force · High confidence | Lensar, Inc. | In force | High confidence | ||
| US 11,571,335 | Laser System for Eye Surgery In force · High confidence | Lensar, Inc. | In force | High confidence | ||
| US 12,343,284 | Combined Laser and Phacoemulsification System for Eye Surgery In force · Low confidence | Lensar, Inc. | In force | Low confidence | ||
| US 9,259,354 | Laser Delivery System for Eye Surgery In force · High confidence | Lensar, Inc. | In force | High confidence | ||
| US 12,350,196 | Combined Laser and Phacoemulsification System for Eye Surgery In force · Medium confidence | Lensar, Inc. | In force | Medium confidence | ||
| Application 18/105,900 | Laser System for Eye Surgery Pending Not granted | Lensar, Inc. | Pending | Not granted | ||
| Application 19/255,251 | Combined Laser and Phacoemulsification System for Eye Surgery Pending Not granted | Lensar, Inc. | Pending | Not granted |
7 of 7 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
5 of these are in force and held by Lensar, Inc..
Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.